Steroid Hormone Bioavailability defines the fraction of administered or endogenously produced steroid hormones, such as testosterone or cortisol, that is unbound to plasma proteins and thus free to interact with intracellular receptors to exert a biological effect. Only this unbound fraction is functionally active in target tissues, making it a critical measure of endocrine potential. It separates mere presence from actual physiological impact.
Origin
This term arises because most circulating steroid hormones are lipophilic and require binding to carrier proteins like SHBG or albumin for transport in the aqueous plasma. Recognizing that binding capacity varies significantly among individuals necessitated a focus on the free hormone level as the true indicator of endocrine status. It is a refinement of basic hormone measurement.
Mechanism
Bioavailability is mechanistically governed by the concentration and binding affinity of SHBG and corticosteroid-binding globulin (CBG), which are themselves regulated by factors like thyroid status and liver function. A change in the concentration of these binding proteins directly alters the equilibrium, shifting the amount of active hormone available to diffuse into target cells and initiate genomic or non-genomic signaling.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.